In patients with BML in the medial compartment at baseline , the BML score at @months was decreased in both treatment groups compared with the placebo group ( SrRan @g/day , p = @ and SrRan @g/day p = @ , respectively ) , and CVL significantly decreased with SrRan @g/day ( p = @ ) in the plateau compared with placebo .